SightfileU.S. market data from official filings

Companies › ELTP

ELITE PHARMACEUTICALS INC COM NEW (ELTP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001053369 · EDGAR filings · Updated 2026-06-29

ELITE PHARMACEUTICALS INC COM NEW (ELTP) has 1 institutional managers reporting positions valued at $180 per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional managers
1
Reported 13F value
$180
Insider activity
7 trans.
−$862.3K net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ELITE PHARMACEUTICALS INC COM NEW has 1 institutional holders.

Insider activity

Insiders reported 7 transactions (1 buys, 3 sells) across 3 reporting insiders, with a net reported value of −$862.3K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-06-29 (recurring since 2020-02-10) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Edgemode Inc (EDGM) · HEALTHLYNKED CORP COM (HLYK) · PROTOKINETIX INC (PKTX) · CASI PHARMACEUTICALS INC (CASIF)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-29.